Recombinant antigens
gp19
for Ehrlichia canis
gp19 is a major epitope of the bacteria Ehrlichia canis, which can be used for the detection of early acute-phase antibodies and reacts strongly with antibodies in late-acute-phase sera from experimental dogs. gp19 is encoded by a highly conserved single gene that minimizes or eliminates the potential for serologic variability.
- NAME
- Gp19
- DESCRIPTION
- Glycoprotein
- GEN
- gp19
- PURITY
- >95% by observation on SDS-PAGE electrophoresis
- Formats
Liquid solution or dry powder (lyophilised) in vials of 0.1 mg*, 1 mg and bulk.
*under availability, for liquid format
* Our IVD reagents are provided for research and commercial use in vitro: not for human in vivo or therapeutic use. In addition, we follow a rigorous quality control for each lot.
References of Recombinant antigen gp19
Folletos
- Rekom Biotech catalogue
- Recombinant proteins for in vitro diagnosis of human infectious diseases
- Recombinant proteins for in vitro diagnosis of animal infectious diseases
- Rekom Biotech Top products (Satisfaction guarantee)
- Recombinant proteins for vector-borne diseases
- IVD reagents for Transfusion-Transmitted Infectious diseases
Videos
Reagent sheet
- NAME
- gp19
- DESCRIPTION
- Glycoprotein
- PURITY
- >95% by observation on SDS-PAGE electrophoresis
- Formats
Liquid solution or dry powder (lyophilised) in vials of 0.1 mg*, 1 mg and bulk.
*under availability, for liquid format
* Our IVD reagents are provided for research and commercial use in vitro: not for human in vivo or therapeutic use. In addition, we follow a rigorous quality control for each lot.
